Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Zongertinib
Generic name : Hernexeos
Manufactured By : BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Indications : METASTATIC NON SQUAMOUS NSCLC HER2(ERBB2) TKD ACTIVATING MUTATIONS
Medicine Description : A targeted oral therapy for non-squamous NSCLC with HER2 (ERBB2) tyrosine kinase domain activating mutations, Zongertinib (Hernexeos) selectively inhibits HER2 to slow tumor growth. Approved for adults with unresectable or metastatic disease after prior systemic therapy. Taken orally, it improves response rates and progression-free survival. Common side effects include diarrhea, liver enzyme elevations, fatigue, nausea, and rash. Monitoring is needed for interstitial lung disease, heart function, and liver toxicity.